| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-05648-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-92000-0.02ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-03710-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-93016-0.02ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50431-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12050-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP1-06696-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-90611-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-90030-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-06616-50ul | |||
![Western Blot: Uev1a/UBE2V1 Antibody [NBP3-05648] - Western blot analysis of extracts of various cell lines, using Uev1a/UBE2V1 antibody (NBP3-05648) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 90s.](http://images.novusbio.com/fullsize/Uev1a-UBE2V1-Antibody-Western-Blot-NBP3-05648-img0001.jpg "Western Blot: Uev1a/UBE2V1 Antibody [NBP3-05648] - Western blot analysis of extracts of various cell lines, using Uev1a/UBE2V1 antibody (NBP3-05648) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 90s.")
![Western Blot: ITCH/AIP4 Antibody [NBP2-81837] - Western blot analysis of ITCH/AIP4 in 3T3 cell lysate with ITCH/AIP4 antibody at 1 ug/ml in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/ITCH-AIP4-Antibody-Western-Blot-NBP2-81837-img0001.jpg "Western Blot: ITCH/AIP4 Antibody [NBP2-81837] - Western blot analysis of ITCH/AIP4 in 3T3 cell lysate with ITCH/AIP4 antibody at 1 ug/ml in (A) the absence and (B) the presence of blocking peptide.")
![Western Blot: AP1M1 Antibody [NBP2-92000] - analysis of various lysates, using AP1M1 antibody at 1:1000 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25 ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit. Exposure time: 30s.](http://images.novusbio.com/fullsize/nbp2-92000_rabbit-polyclonal-ap1m1-antibody-western-blot-13920239300..jpg "Western Blot: AP1M1 Antibody [NBP2-92000] - analysis of various lysates, using AP1M1 antibody at 1:1000 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25 ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit. Exposure time: 30s.")
![Western Blot: RALBP1 Antibody [NBP3-03710] - Analysis of extracts of various cell lines, using RALBP1 antibody at 1:500 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST.](http://images.novusbio.com/fullsize/RALBP1-Antibody-Western-Blot-NBP3-03710-img0004.jpg "Western Blot: RALBP1 Antibody [NBP3-03710] - Analysis of extracts of various cell lines, using RALBP1 antibody at 1:500 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST.")
![<b>Genetic Strategies Validation. </b>Western Blot: RALBP1 Antibody [NBP3-03710] - Analysis of extracts from normal (control) and RALBP1 knockout (KO) HeLa cells, using RALBP1 antibody at 1:500 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: Blocking buffer: 3% nonfat dry milk in TBST.](http://images.novusbio.com/fullsize/RALBP1-Antibody-Knockout-Validated-NBP3-03710-img0003.jpg)
![SDS-Page: Recombinant Human Integrin beta 2/CD18 Protein [NBP2-52351] - 15% SDS Page (3 ug)](http://images.novusbio.com/fullsize/Integrin-beta-2-CD18-Recombinant-Protein-SDS-Page-NBP2-52351-img0001.jpg "SDS-Page: Recombinant Human Integrin beta 2/CD18 Protein [NBP2-52351] - 15% SDS Page (3 ug)")
![Western Blot: SNRPB2 Antibody [NBP2-93016] - Analysis of extracts of various cell lines, using SNRPB2 at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit . Exposure time: 90s.](http://images.novusbio.com/fullsize/SNRPB2-Antibody-Western-Blot-NBP2-93016-img0001.jpg "Western Blot: SNRPB2 Antibody [NBP2-93016] - Analysis of extracts of various cell lines, using SNRPB2 at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit . Exposure time: 90s.")
![Immunohistochemistry-Paraffin: BCAM/CD239 Antibody (MM0107-1M39) [NBP2-12050] - 4% PFA fixed and parffine embedded human placental tissue section (4um) is subjected to IHC staining. Tissue was treated with 15ug/ml Protenase for antige retrieval before IHC is applied.](http://images.novusbio.com/fullsize/BCAM-CD239-Antibody-MM0107-1M39-Immunohistochemistry-Paraffin-NBP2-12050-img0001.jpg "Immunohistochemistry-Paraffin: BCAM/CD239 Antibody (MM0107-1M39) [NBP2-12050] - 4% PFA fixed and parffine embedded human placental tissue section (4um) is subjected to IHC staining. Tissue was treated with 15ug/ml Protenase for antige retrieval before IHC is applied.")
![Immunohistochemistry-Paraffin: RP105/CD180 Antibody (105) [NBP2-90611] - Immunochemical staining of mouse RP105/CD180 in mouse thymus with rabbit monoclonal antibody (1:100, formalin-fixed paraffin embedded sections).](http://images.novusbio.com/fullsize/RP105-CD180-Antibody-105-Immunohistochemistry-Paraffin-NBP2-90611-img0002.jpg "Immunohistochemistry-Paraffin: RP105/CD180 Antibody (105) [NBP2-90611] - Immunochemical staining of mouse RP105/CD180 in mouse thymus with rabbit monoclonal antibody (1:100, formalin-fixed paraffin embedded sections).")
![Immunohistochemistry-Paraffin: RP105/CD180 Antibody (105) [NBP2-90611] - Immunochemical staining of mouse RP105/CD180 in mouse spleen with rabbit monoclonal antibody (1:100, formalin-fixed paraffin embedded sections).](http://images.novusbio.com/fullsize/RP105-CD180-Antibody-105-Immunohistochemistry-Paraffin-NBP2-90611-img0001.jpg)
![Immunohistochemistry-Paraffin: Siglec-2/CD22 Antibody (340) [NBP2-90030] - Staining of human CD22 in human tonsil with rabbit monoclonal antibody at 1:200 dilution.](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-340-Immunohistochemistry-Paraffin-NBP2-90030-img0003.jpg "Immunohistochemistry-Paraffin: Siglec-2/CD22 Antibody (340) [NBP2-90030] - Staining of human CD22 in human tonsil with rabbit monoclonal antibody at 1:200 dilution.")
![Immunohistochemistry-Paraffin: Siglec-2/CD22 Antibody (340) [NBP2-90030] - Staining of human CD22 in human spleen with rabbit monoclonal antibody at 1:200 dilution.](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-340-Immunohistochemistry-Paraffin-NBP2-90030-img0002.jpg)
![Flow Cytometry: ITCH/AIP4 Antibody (01) [NBP3-06616] - Analysis of Human ITCH expression on HeLa cells. The cells were treated, stained with purified anti-Human ITCH, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/ITCH-AIP4-Antibody-01-Flow-Cytometry-NBP3-06616-img0002.jpg "<b>Biological Strategies Validation. </b>Flow Cytometry: ITCH/AIP4 Antibody (01) [NBP3-06616] - Analysis of Human ITCH expression on HeLa cells. The cells were treated, stained with purified anti-Human ITCH, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.")
![<b>Biological Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: ITCH/AIP4 Antibody (01) [NBP3-06616] - Staining of Human ITCH in Hela cells. Cells were fixed with 4% PFA, permeabilzed with 1% Triton X-100 in PBS, blocked with 10% serum, and incubated with NBP3-06616 antibody (1:60) at 37? 1 hour. Then cells were stained with the Alexa Fluor 488-conjugated Goat Anti-mouse IgG secondary antibody (green) and counterstained with DAPI (blue). Positive staining was localized to cytoplasm.](http://images.novusbio.com/fullsize/nbp3-06616_mouse-monoclonal-itch-aip4-antibody-01-23520251433151.png)